The U.S. government named 15 drugs that will be subject to the second round of price negotiations by Medicare, including ...

On the post-earnings call with analysts, Chief Executive Andrew Witty addressed the recent public backlash over high drug costs and transparency of coverage, particularly following killing of Brian ...

UnitedHealth posted a better-than-expected profit in the final quarter of 2024, but a nagging rise in medical costs and care utilization surprised Wall Street.

Adjusted per-share earnings in the fourth quarter for UnitedHealth top analysts’ estimates but revenue comes up short.

The company is at a pivotal point following the killing of Brian Thompson, who headed the UnitedHealthcare unit, and there was a public outcry about insurance denials. That prompted Andrew Witty, the ...

Elevance Health Inc. closed $174.10 below its 52-week high ($567.26), which the company achieved on September 3rd.

The S&P 500 and Nasdaq have both felt pressure as shares of major tech companies came under pressure Monday. Investors ...